Literature DB >> 11818541

The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

M Resnati1, I Pallavicini, J M Wang, J Oppenheim, C N Serhan, M Romano, F Blasi.   

Abstract

The function of urokinase and its receptor is essential for cell migration in pathological conditions, as shown by the analysis of knockout mice phenotypes. How a protease of a fibrinolytic pathway can induce migration is not understood and no link between this protease and migration-promoting G protein-coupled receptors has been described. We now show that FPRL1/LXA4R, a G protein-coupled receptor for a number of polypeptides and for the endogenous lipoxin A4 (LXA4), is the link between urokinase-type plasminogen activator (uPA) and migration as it directly interacts with an activated, soluble, cleaved form of uPA receptor (uPAR) (D2D3(88-274)) to induce chemotaxis. In this article we show that (i) both uPAR and FPRL1/LXA4R are necessary for the chemotactic activity of uPA whereas FPRL1/LXA4R is sufficient to mediate D2D3(88-274)-induced cell migration. (ii) Inhibition or desensitization of FPRL1/LXA4R by antibodies or specific ligands specifically prevents chemotaxis induced by D2D3(88-274) in THP-1 cells and human peripheral blood monocytes. (iii) Desensitization of FPRL1/LXA4R prevents the activation of tyrosine kinase Hck induced by D2D3(88-274). (iv) D2D3(88-274) directly binds to FPRL1/LXA4R and is competed by two specific FPRL1/LXA4R agonists, the synthetic MMK-1 peptide and a stable analog of LXA4. Thus, a naturally produced cleaved form of uPAR is a unique endogenous chemotactic agonist for FPRL1/LXA4R receptor and its activity can be antagonized by specific ligands. These results provide the first direct link, to our knowledge, between the fibrinolytic machinery and the inflammatory response, demonstrating that uPA-derived peptide fragments can activate a specific chemotactic receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818541      PMCID: PMC122195          DOI: 10.1073/pnas.022652999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Urokinase receptor: a molecular organizer in cellular communication.

Authors:  K T Preissner; S M Kanse; A E May
Journal:  Curr Opin Cell Biol       Date:  2000-10       Impact factor: 8.382

2.  Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo.

Authors:  N Sidenius; C F Sier; F Blasi
Journal:  FEBS Lett       Date:  2000-06-09       Impact factor: 4.124

3.  Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection.

Authors:  M R Gyetko; S Sud; T Kendall; J A Fuller; M W Newstead; T J Standiford
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

4.  Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils.

Authors:  R G Sitrin; P M Pan; H A Harper; R F Todd; D M Harsh; R A Blackwood
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 5.  Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

Authors:  L Ossowski; J A Aguirre-Ghiso
Journal:  Curr Opin Cell Biol       Date:  2000-10       Impact factor: 8.382

6.  Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

Authors:  H M Zhou; A Nichols; P Meda; J D Vassalli
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.

Authors:  R W Stephens; H J Nielsen; I J Christensen; O Thorlacius-Ussing; S Sørensen; K Danø; N Brünner
Journal:  J Natl Cancer Inst       Date:  1999-05-19       Impact factor: 13.506

8.  Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.

Authors:  N Sidenius; C F Sier; H Ullum; B K Pedersen; A C Lepri; F Blasi; J Eugen-Olsen
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

9.  Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.

Authors:  D J Webb; D H Nguyen; S L Gonias
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

Review 10.  The scent of a phagocyte: Advances on leukotriene b(4) receptors.

Authors:  C N Serhan; S M Prescott
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  124 in total

1.  Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.

Authors:  Fang Wang; W Eric Knabe; Liwei Li; Inha Jo; Timmy Mani; Hartmut Roehm; Kyungsoo Oh; Jing Li; May Khanna; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2012-06-12       Impact factor: 3.641

Review 2.  New development in studies of formyl-peptide receptors: critical roles in host defense.

Authors:  Liangzhu Li; Keqiang Chen; Yi Xiang; Teizo Yoshimura; Shaobo Su; Jianwei Zhu; Xiu-wu Bian; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2015-12-23       Impact factor: 4.962

3.  Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.

Authors:  Sara Rezzola; Michela Corsini; Paola Chiodelli; Anna Cancarini; Imtiaz M Nawaz; Daniela Coltrini; Stefania Mitola; Roberto Ronca; Mirella Belleri; Liliana Lista; Dario Rusciano; Mario De Rosa; Vincenzo Pavone; Francesco Semeraro; Marco Presta
Journal:  Diabetologia       Date:  2017-01-13       Impact factor: 10.122

4.  Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Authors:  Andrew S Gilder; Karra A Jones; Jingjing Hu; Lei Wang; Clark C Chen; Bob S Carter; Steven L Gonias
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

5.  A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.

Authors:  Evelyn C Nieves; Naveen Manchanda
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

6.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

7.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

Review 8.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

9.  Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

Authors:  Sean T Zuckerman; James F Brown; Weiyuan J Kao
Journal:  Biomaterials       Date:  2009-05-14       Impact factor: 12.479

Review 10.  Lipoxins: resolutionary road.

Authors:  Paola Maderna; Catherine Godson
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.